KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Depreciation & Amortization (CF) (2018 - 2025)

Historic Depreciation & Amortization (CF) for ClearPoint Neuro (CLPT) over the last 13 years, with Q3 2025 value amounting to $322000.0.

  • ClearPoint Neuro's Depreciation & Amortization (CF) rose 2196.97% to $322000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 815.49%. This contributed to the annual value of $980000.0 for FY2024, which is 1793.02% up from last year.
  • Latest data reveals that ClearPoint Neuro reported Depreciation & Amortization (CF) of $322000.0 as of Q3 2025, which was up 2196.97% from $268000.0 recorded in Q2 2025.
  • In the past 5 years, ClearPoint Neuro's Depreciation & Amortization (CF) registered a high of $322000.0 during Q3 2025, and its lowest value of $133000.0 during Q1 2021.
  • For the 5-year period, ClearPoint Neuro's Depreciation & Amortization (CF) averaged around $194631.6, with its median value being $183000.0 (2023).
  • Data for ClearPoint Neuro's Depreciation & Amortization (CF) shows a peak YoY increase of 14603.66% (in 2021) and a maximum YoY decrease of 1887.42% (in 2021) over the last 5 years.
  • Over the past 5 years, ClearPoint Neuro's Depreciation & Amortization (CF) (Quarter) stood at $133000.0 in 2021, then changed by 0.0% to $133000.0 in 2022, then soared by 81.2% to $241000.0 in 2023, then decreased by 0.41% to $240000.0 in 2024, then soared by 34.17% to $322000.0 in 2025.
  • Its last three reported values are $322000.0 in Q3 2025, $268000.0 for Q2 2025, and $231000.0 during Q1 2025.